Inspired by the CRISPR screen and expression correlation evidence in AML pathogenesis, we reasoned the regulatory function of the RBM5/HOXA9 circuitry in the AML context could be verified by loss-of-function studies. Here, RBM5 is linked to acute myeloid leukemia.